Skip to content
Home/Companies/Pharma/Orsini Pharmaceutical Services

Orsini Pharmaceutical Services

Pharma·Japan·Active
Entry
–
Hold
–
Status
Active

Who owns Orsini Pharmaceutical Services?

Orsini Pharmaceutical Services is currently owned by The Carlyle Group through Carlyle Japan (2022 vintage).

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Carlyle Japan · 2022 · Growth

Key facts

HQJapan
SectorPharma

More from Carlyle Japan

Other portfolio companies in the same fund.

CureApp Inc.
CureApp Inc.
Active
HealthTechJapan
Kyoden Co., Ltd.
Active
IndustrialsJapan
Money Square Holdings, Inc.
Exited 2022
FintechJapan
to
Orion Breweries, Ltd.
Orion Breweries, Ltd.
Active
ConsumerJapan
Oyatsu Company Limited
Exited 2022
ConsumerJapan
to
Psychiatric Medical Care
Active
HealthcareJapan

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Jubilant Life Sciences
Active
General AtlanticIndia
Track Orsini Pharmaceutical Services

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Orsini Pharmaceutical Services?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Orsini Pharmaceutical Services.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue